| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/163.6.1235 |
| P698 | PubMed publication ID | 2037789 |
| P2093 | author name string | Rao MR | |
| Harris JR | |||
| Sack DA | |||
| Yunus M | |||
| Clemens JD | |||
| Khan MR | |||
| Chakraborty J | |||
| Ahmed F | |||
| Huda S | |||
| van Loon F | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Bangladesh | Q902 |
| cholera | Q12090 | ||
| antibody | Q79460 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1235-1242 | |
| P577 | publication date | 1991-06-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. | |
| P478 | volume | 163 |
| Q36551627 | A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali |
| Q39744171 | Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi |
| Q51978021 | B-cell responses to lipopolysaccharide epitopes: Who sees what first - does it matter? |
| Q35353453 | Cholera as a model for research on mucosal immunity and development of oral vaccines |
| Q30235247 | Cholera. |
| Q36277234 | Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea |
| Q78862034 | Construction and characterisation of O139 cholera vaccine candidates |
| Q41820352 | Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera: relevance to vaccine immunogenicity |
| Q74401546 | Efficacy of a food plant-based oral cholera toxin B subunit vaccine |
| Q92506600 | Epidemiology of cholera |
| Q34883543 | Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate |
| Q35236588 | Expression and functional validation of heat-labile enterotoxin B (LTB) and cholera toxin B (CTB) subunits in transgenic rice (Oryza sativa). |
| Q35460365 | Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera. |
| Q37102102 | Genomic correlates of variability in immune response to an oral cholera vaccine |
| Q37544969 | Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry |
| Q37340450 | Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length |
| Q72546119 | Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice |
| Q57952619 | Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model |
| Q36320323 | Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections |
| Q30151668 | Improving immunization approaches to cholera |
| Q36945363 | Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine |
| Q39144090 | Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization |
| Q33877413 | Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria |
| Q37953796 | New-generation vaccines against cholera |
| Q24235775 | Oral vaccines for preventing cholera |
| Q33756057 | Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers |
| Q73443851 | Purified cholera toxin B subunit from transgenic tobacco plants possesses authentic antigenicity |
| Q84066281 | Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response |
| Q35485187 | Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines. |
| Q21090119 | Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks |
| Q64951541 | Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India. |
| Q35399988 | Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults |
| Q33830466 | Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India. |
| Q72152637 | Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype |
| Q33609081 | Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels |
| Q37180547 | Spatial and environmental connectivity analysis in a cholera vaccine trial |
| Q36949262 | Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin |
| Q36688241 | The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine |
| Q33908873 | Vaccines for preventing cholera |
Search more.